Harriet having it all
From Boston to Moscow and across the U.S., Harriet Latham Robinson SM ’61, PhD ’65 has balanced an exciting career at the forefront of molecular biology with family, friends, and adventure.
The long history of vaccine hesitancy
Thomas Levenson’s new book shows how arguments against vaccination reach back to the beginning of the technology itself.
A new vaccine adjuvant could make it easier to eradicate polio
The adjuvant can help the injectable polio vaccine induce a strong immune response in the GI tract, which is considered critical to eradicating the virus.
A new approach to cancer vaccination yields more powerful T cells
Using immune-remodeling mRNA molecules, researchers generated T cells that can slow tumor growth and, in some cases, eradicate tumors.
New vaccine platform promotes rare protective B cells
Based on a virus-like particle built with a DNA scaffold, the approach could generate broadly neutralizing antibody responses against HIV or influenza.
Particles that enhance mRNA delivery could reduce vaccine dosage and costs
Using these nanoparticles to deliver a flu vaccine, researchers observed an effective immune response at a much lower dose.
MIT study finds targets for a new tuberculosis vaccine
Using these antigens, researchers plan to develop vaccine candidates that they hope would stimulate a strong immune response against the world’s deadliest pathogen.
Five with MIT ties elected to National Academy of Medicine for 2025
Professors Facundo Batista and Dina Katabi, along with three additional MIT alumni, are honored for their outstanding professional achievement and commitment to service.
MIT researchers develop AI tool to improve flu vaccine strain selection
VaxSeer uses machine learning to predict virus evolution and antigenicity, aiming to make vaccine selection more accurate and less reliant on guesswork.
How AI could speed the development of RNA vaccines and other RNA therapies
MIT engineers used a machine-learning model to design nanoparticles that can deliver RNA to cells more efficiently.
Supercharged vaccine could offer strong protection with just one dose
By delivering an HIV vaccine candidate along with two adjuvants, researchers showed they could generate many more HIV-targeting B cells in mice.
Study in India shows several tactics together boost vaccination against deadly diseases
One combination of methods led to a 44 percent increase in child immunizations.
Particles carrying multiple vaccine doses could reduce the need for follow-up shots
MIT engineers designed polymer microparticles that can deliver vaccines at predetermined times after injection.
Biologists identify targets for new pancreatic cancer treatments
Their study yielded hundreds of “cryptic” peptides that are found only on pancreatic tumor cells and could be targeted by vaccines or engineered T cells.
Is this the new playbook for curing rare childhood diseases?
When his son received a devastating diagnosis, Fernando Goldsztein MBA ’03 founded an initiative to help him and others.